Cargando...
Nonparametric Benefit–Risk Assessment Using Marker Process in the Presence of a Terminal Event
Benefit–risk assessment is a crucial step in medical decision process. In many biomedical studies, both longitudinal marker measurements and time to a terminal event serve as important endpoints for benefit–risk assessment. The effect of an intervention or a treatment on the longitudinal marker proc...
Guardado en:
| Publicado en: | J Am Stat Assoc |
|---|---|
| Autores principales: | , , |
| Formato: | Artigo |
| Lenguaje: | Inglês |
| Publicado: |
2017
|
| Materias: | |
| Acceso en línea: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5935274/ https://ncbi.nlm.nih.gov/pubmed/29731529 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/01621459.2016.1180988 |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|